Carcinoid heart disease
- PMID: 17498524
- DOI: 10.1016/j.pcad.2006.12.002
Carcinoid heart disease
Abstract
Carcinoid heart disease is a rare form of valvular heart disease. The management of these patients is complex, as the systemic malignant disease and the cardiac involvement have to be considered at the same time. Progress in the treatment of patients with carcinoid disease has resulted in improved symptom control and survival. Development and progression of carcinoid heart disease are associated with increased morbidity and mortality. In patients with severe cardiac involvement and well-controlled systemic disease, cardiac surgery has been recognized as the only effective treatment option. Valve replacement surgery may not only be beneficial in terms of symptom relief, but may also contribute to the improved survival observed over the past 2 decades in patients with carcinoid heart disease. Early diagnosis and early surgical treatment in appropriately selected patients may provide the best results. In this article, we review the current literature regarding the biology, diagnosis, treatment, and prognosis of carcinoid heart disease.
Similar articles
-
Surgery for carcinoid heart disease: current outcomes, concerns and controversies.Future Cardiol. 2010 Sep;6(5):647-55. doi: 10.2217/fca.10.87. Future Cardiol. 2010. PMID: 20932113 Review.
-
Carcinoid heart disease: current understanding and future directions.Am Heart J. 2014 Jun;167(6):789-95. doi: 10.1016/j.ahj.2014.03.018. Epub 2014 Apr 5. Am Heart J. 2014. PMID: 24890526 Review.
-
[Carcinoid heart disease].Arch Mal Coeur Vaiss. 1998 Jan;91(1):79-82. Arch Mal Coeur Vaiss. 1998. PMID: 9749268 French.
-
Carcinoid heart disease.Cardiol Rev. 2012 Jul-Aug;20(4):167-76. doi: 10.1097/CRD.0b013e31824c866e. Cardiol Rev. 2012. PMID: 22314145 Review.
-
[Carcinoid tumors].Orv Hetil. 2002 May 12;143(19 Suppl):1087-92. Orv Hetil. 2002. PMID: 12063867 Review. Hungarian.
Cited by
-
Clinical Issues Related to Fluid Management during 177Lu-Peptide Receptor Radionuclide Therapy in Metastatic Neuroendocrine Tumors with Carcinoid Heart Disease.Indian J Nucl Med. 2018 Oct-Dec;33(4):359-361. doi: 10.4103/ijnm.IJNM_83_18. Indian J Nucl Med. 2018. PMID: 30386064 Free PMC article. No abstract available.
-
Demonstration of TGF-β and XIIIα in Endocardial Biopsies of Carcinoid Heart Disease Patients: an Immunofluorescence Study.Cardiol Res. 2011 Jun;2(3):119-122. doi: 10.4021/cr48w. Epub 2011 May 20. Cardiol Res. 2011. PMID: 28352378 Free PMC article.
-
Complications from carcinoid syndrome: review of the current evidence.Ecancermedicalscience. 2016 Aug 8;10:662. doi: 10.3332/ecancer.2016.662. eCollection 2016. Ecancermedicalscience. 2016. PMID: 27594907 Free PMC article. Review.
-
Myocardial metastases on 6-[18F] fluoro-L-DOPA PET/CT: a retrospective analysis of 116 serotonin producing neuroendocrine tumour patients.PLoS One. 2014 Nov 14;9(11):e112278. doi: 10.1371/journal.pone.0112278. eCollection 2014. PLoS One. 2014. PMID: 25397775 Free PMC article.
-
Double valve replacement in a case of Hedinger syndrome.Clin Case Rep. 2023 Jan 19;11(1):e6836. doi: 10.1002/ccr3.6836. eCollection 2023 Jan. Clin Case Rep. 2023. PMID: 36698512 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous